Teva Pharmaceuticals
TEVA
TEVA
821 hedge funds and large institutions have $31.1B invested in Teva Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 276 increasing their positions, 301 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.15% more ownership
Funds ownership: 52.74% → 54.89% (+2.1%)
5% more capital invested
Capital invested by funds: $29.6B → $31.1B (+$1.43B)
8% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 301
Holders
821
Holding in Top 10
59
Calls
$745M
Puts
$592M
Top Buyers
| 1 | +$409M | |
| 2 | +$352M | |
| 3 | +$275M | |
| 4 |
Neuberger Berman Group
New York
|
+$201M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$152M |
Top Sellers
| 1 | -$1.95B | |
| 2 | -$369M | |
| 3 | -$282M | |
| 4 |
PC
PointState Capital
New York
|
-$132M |
| 5 |
D.E. Shaw & Co
New York
|
-$93.7M |